2-TOET

2-TOET
Clinical data
Other names2-Methylthio-4-ethyl-5-methoxyamphetamine; 4-Ethyl-2-methylthio-5-methoxyamphetamine; 2-Thio-DOET; 2T-DOET; 2-Methylthio-DOET
Routes of
administration
Oral
Drug classPsychoactive drug
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown (but long-lasting)
Identifiers
  • 1-(4-ethyl-5-methoxy-2-methylsulfanylphenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC13H21NOS
Molar mass239.38 g·mol−1
3D model (JSmol)
  • CCC1=CC(=C(C=C1OC)CC(C)N)SC
  • InChI=1S/C13H21NOS/c1-5-10-8-13(16-4)11(6-9(2)14)7-12(10)15-3/h7-9H,5-6,14H2,1-4H3
  • Key:TZIBUOSWJBKVTA-UHFFFAOYSA-N

2-TOET, also known as 2-methylthio-4-ethyl-5-methoxyamphetamine or as 2-thio-DOET, is a psychoactive drug of the phenethylamine and amphetamine families related to the DOx psychedelic DOET. It is the analogue of DOET in which the methoxy group at the 2 position has been replaced with a methylthio group. The drug is one of two possible TOET (thio-DOET) positional isomers, the other being 5-TOET.

In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 2-TOET's dose as greater than 65 mg orally and its duration as unknown (but long-lasting). The drug is more than 10-fold less potent than DOET, which has a listed dose range of 2 to 6 mg orally.

The effects of 2-TOET have been reported to include slight lightheadedness, feeling physically a bit fragile, possible appetite loss, possible erectile dysfunction, and next-day residual fragility. It was described as inactive as a hallucinogen at assessed doses, and higher doses were not tested.

The chemical synthesis of 2-TOET has been described. The phenethylamine analogue, 2C-2-TOET (2-thio-2C-E), has been synthesized, but was not tested and its properties are unknown.

2-TOET was first described in the scientific literature by Alexander Shulgin and Peyton Jacob III in 1983. Subsequently, it was described in greater detail by Shulgin in PiHKAL in 1991.

See also